Ann: ATL1103/atesidorsen Early Access Program - Update, page-41

After 17 years and $57 million dollars (yes that is the contributed equity) what have "we" actually built here. Quite incredible that we still seem to be at square one in 2018.

In 2001 we had an A-team of Australian bio-tech brains and a tie to super star bio-tech IONS in the USA. 17 years late I never hear these people/partners mentioned. All they have done is dilute themselves to smaller and smaller positions.

Mark Diamond after 17 years has bought tiny tiny token amounts of stock on mkt and only owns a paltry 1.9 million shares after all these years. That alone is the warning sign we should all have listened to and the reason this stock needs new management & passion, but no one on the share register really seems to care or understand what we are really doing here day to day.

Having said all that one thing has always worked, buy ANP around $5 million market capitalisation. It has always jumped to $15 to $20 million mkt cap after plumbing those depth and we seem to be bouncing out of $5m Mkt Cap again, with a very nice technical set up as long as we hold 3.3/3.5 cents. This paragraph below in the half yearly gives some near term hope for at least a good trade here.

"After consideration of the available facts the Directors have concluded that the going concern basis is appropriate given the Company’s track record of raising capital and the status of ongoing discussions with various parties"